反复自然流产专家是谁?Who is the expert on recurrent spontaneous miscarriage?

反复自然流产只是一种表现，导致反复自然流产的疾病上百种，哪些专家才是治疗反复自然流产的高手呢?很多病人都推荐陈凤林教授。那么谁是陈凤林，他在习惯性流产疾病方面都有哪些成就呢?

Repeated spontaneous miscarriage is only a manifestation, leading to repeated spontaneous miscarriage of hundreds of diseases, which experts are the masters of the treatment of repeated spontaneous miscarriage? Many patients recommend Professor Chenfenglin. So who is Chenfenglin and what are his achievements in the area of habitual miscarriage?

陈凤林，复发性自然流产( Miscarriage)国际权威专家，被业内称为流产狙击手，因为他对复发性自然流产第一次进行了科学分类，发明了免疫性复发性自然流产特异性诊断试剂盒和特效治疗基因疫苗，获得北京科技进步二等奖，美、欧盟、中国发明专利。此后，他又对子宫纵膈发明了冷刀分离和梨形支架防粘术;对重度宫腔粘连实施异体子宫粘膜移植防粘术;针对单、残角子宫，双子宫发明了腹腔镜下子宫融合术;还有针对黄体功能不足发明了，按量补充，递减停药法。他还发明了宫颈埋箍术，彻底阻止了宫颈松弛引起的晚期复发性流产。在陈凤林的手里，98%的复发性自然流产都有确切有效的诊疗方法。

Chenfenglin, an international authoritative expert on recurrent spontaneous miscarriage, was called an miscarriage sniper by the industry because he first performed a scientific classification of recurrent spontaneous miscarriage and invented a specific diagnostic kit for immune recurrent spontaneous miscarriage. And special effects treatment gene vaccine, won the second prize of Beijing Science and Technology Progress Award, American, European Union, Chinese invention patent. Since then, he has invented cold knife separation and pear-shaped stent anti-adhesion surgery for the uterine mediastinal; The uterine mucosal transplantation of severe uterine adhesion was performed. For single and residual horns of the uterus, double uterus invented laparoscopic uterine fusion; There is also an invention for the insufficient function of the luteal body. He also invented cervical banding, which completely prevented late recurrent miscarriage caused by cervical relaxation. In the hands of Chenfenglin, 98 % of recurrent spontaneous miscarriages have exact and effective methods of diagnosis and treatment.

复发性自然流产不是一个独立疾病，病因繁杂。原来分类和诊断都不清晰，更无有效治疗措施，成为医学界的一大难题。

Recurrent spontaneous miscarriage is not an independent disease and the cause is complicated. The original classification and diagnosis are not clear, and there is no effective treatment measure, which has become a major problem in the medical community.

陈凤林医生终身专注研究复发性自然流产，按照早期、晚期、原发和继发四点进行了科学分类和病因排序，免疫因素占67%，解剖因素占14%，内分泌因素占11%，其他8%。特别是对发病率最高免疫性早期继发复发性自然流产进行基础研究，发现真正的病因是人工流产导致体内产生抗胚胎抗体，在此基础上研发基因疫苗，阐明了免疫性早期复发性流产的病因，诊断和治疗。

Dr Chenfenglin has devoted his life to the study of recurrent spontaneous miscarriage. He has scientific classification and etiology according to the early, late, primary, and secondary four points. Immunological factors account for 67 %, anatomical factors account for 14 %, endocrine factors account for 11 %, and other 8 %. In particular, the basic study of the highest incidence of immune-induced recurrent spontaneous miscarriage in the early stage found that the real cause of miscarriage is the production of anti-embryo antibodies in the body. Based on this, a gene vaccine was developed to clarify the causes, diagnosis and treatment of immune-induced early recurrent miscarriage.

陈凤林2003年凭借复发性自然流产的技术，在上海联创风险投资公司融资2000万人民币，建立北京安太医疗技术服务有限公司和安太嘉园医院，医院以“安胎”谐音安太命名，主要是治疗各类 复发性自然流产，首开承诺制先河，实行签约治疗，达不到目的退全款，改写传统医疗模式。经治各类复发性自然流产2万余例，成功率高达98%，医院也利润率高达30%。2015年公司成功的进行了二次融资。

In 2003, Chenfenglin used the technology of recurrent spontaneous miscarriage to raise 20 million yuan at Shanghai Lianchuang Venture Capital Co., Ltd. to establish Beijing Antai Medical Technology Service Co., Ltd. and Antai Jiayuan Hospital. The hospital was named after Xieyinan. It is mainly for the treatment of all types of recurrent spontaneous miscarriage, and it is the first to set a precedent for the commitment system and implement contract treatment. Failure to achieve the goal of full repayment, rewriting the traditional medical model. After the treatment of more than 20,000 cases of recurrent spontaneous miscarriage, the success rate was as high as 98 %, and the hospital's profit margin was as high as 30 %. In 2015, the company successfully carried out secondary financing.

陈凤林现在持有北京安太医疗技术服务有限公司30%的股份和复发性自然流产的发明专利，正在全球寻找合作者，欲将专利中的试剂盒和疫苗进行完善和开发，使之产品化商业化，造福人类。

Chenfenglin now holds 30 % of the shares of Beijing Antai Medical Technology Services Co., Ltd. and the invention patent of recurrent spontaneous miscarriage. He is looking for collaborators around the world to perfect and develop the kit and vaccine in the patent, making it a product. Commercialization, for the benefit of mankind.

陈凤林被国内外中英文媒体多次报道，如：CCTV1，CCTV2，山东电视台，湖北电视台，人民日报、科技日报、生活时报、环球时报、法新社等。还建立了相关网站：http://www.fenglinchen.com

Chenfenglin was repeatedly reported by Chinese and English media at home and abroad, such as CCTV1, CCTV2, Shandong TV, Hubei TV, People's Daily, Science and Technology Daily, Life Times, Global Times, and AFP. Also established a related website: Http://www.fenglinchen.com